First-in-human trial shows potential of guiding CABG with cardiac CT and AI—no ICA required

HeartFlow FFR-CT

HeartFlow's FFRCT Analysis software in action.

An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFRCT alone. This approach is safe and feasible, researchers wrote, and the next step is to gather additional data. 

Drug price dialogues represent ‘an opportunity for CMS to clarify negotiation policies and their potential impact for the future’

CMS drug price negotiations

Photo by Andrea Piacquadio via Pexels

CMS must ensure transparency, clarity and predictability by providing detailed guidance on comparator drug selection and the evaluation of evidence, according to a group of D.C.-based health policy researchers.